Monday 9th March - Pre-Conference Workshops - PT (Pacific Time, GMT-08:00)
Intensified and continuous bioprocessing is no longer just a vision—it is rapidly becoming a reality across development and commercial manufacturing. This workshop will provide an in-depth exploration of the technologies, strategies, and case studies driving adoption of intensified upstream and downstream processes, as well as integrated continuous platforms.
Participants will gain insights into how companies are designing hybrid and fully continuous systems, leveraging PAT (process analytical technology) to enable real-time monitoring, and overcoming scale-up challenges. Discussions will highlight both the scientific and business advantages of these approaches: higher productivity, reduced costs, greater flexibility, and more sustainable operations.
Goals:
- Review state-of-the-art approaches in intensified and continuous processing for biologics and advanced therapies.
- Understand the technical, operational, and regulatory considerations in moving to continuous systems.
- Learn from real-world case studies of implementation and scale-up.
- Explore how continuous bioprocessing supports faster, more sustainable global access to medicines.
The COVID-19 pandemic and ongoing global pressures have highlighted the fragility of biopharmaceutical supply chains. This workshop will explore how companies are rethinking their supply-chain models for both clinical and commercial supply to ensure continuity, scalability, and resilience.
Industry leaders will address key challenges such as raw material shortages, supplier diversification, just-in-time vs. just-in-case inventory strategies, and the use of digital visibility platforms to improve forecasting and risk management. Special focus will be given to advanced therapies, where supply-chain requirements for personalized products create unique logistical hurdles.
Goals:
- Examine strategies for supply-chain resilience in an unpredictable global environment.
- Understand unique requirements for clinical vs. commercial supply chains.
- Learn how advanced analytics and digital platforms are transforming supply visibility.
- Gain best practices for building strategic supplier partnerships and mitigating risk.
Process characterization is a regulatory requirement and a scientific imperative for developing robust, scalable, and compliant bioprocesses. This workshop will deliver practical tools and advanced strategies for designing and executing process characterization studies that generate actionable insights.
Experts will cover how to define CPPs (critical process parameters) and CQAs (critical quality attributes), apply risk-based approaches, and integrate statistical modeling and digital tools into the characterization framework. Attendees will also gain insights into regulatory expectations, accelerated development timelines, and how leading organizations are future-proofing their process characterization programs to align with evolving global requirements.
Goals:
- Provide proven methodologies for designing and executing effective process characterization studies.
- Share case studies demonstrating speed–quality balance in accelerated development.
- Explore regulatory perspectives on global alignment and expectations.
- Highlight emerging digital and statistical approaches that enhance process understanding.
Intensified and continuous bioprocessing is no longer just a vision—it is rapidly becoming a reality across development and commercial manufacturing. This workshop will provide an in-depth exploration of the technologies, strategies, and case studies driving adoption of intensified upstream and downstream processes, as well as integrated continuous platforms.
Participants will gain insights into how companies are designing hybrid and fully continuous systems, leveraging PAT (process analytical technology) to enable real-time monitoring, and overcoming scale-up challenges. Discussions will highlight both the scientific and business advantages of these approaches: higher productivity, reduced costs, greater flexibility, and more sustainable operations.
Goals:
- Review state-of-the-art approaches in intensified and continuous processing for biologics and advanced therapies.
- Understand the technical, operational, and regulatory considerations in moving to continuous systems.
- Learn from real-world case studies of implementation and scale-up.
- Explore how continuous bioprocessing supports faster, more sustainable global access to medicines.
The COVID-19 pandemic and ongoing global pressures have highlighted the fragility of biopharmaceutical supply chains. This workshop will explore how companies are rethinking their supply-chain models for both clinical and commercial supply to ensure continuity, scalability, and resilience.
Industry leaders will address key challenges such as raw material shortages, supplier diversification, just-in-time vs. just-in-case inventory strategies, and the use of digital visibility platforms to improve forecasting and risk management. Special focus will be given to advanced therapies, where supply-chain requirements for personalized products create unique logistical hurdles.
Goals:
- Examine strategies for supply-chain resilience in an unpredictable global environment.
- Understand unique requirements for clinical vs. commercial supply chains.
- Learn how advanced analytics and digital platforms are transforming supply visibility.
- Gain best practices for building strategic supplier partnerships and mitigating risk.
Process characterization is a regulatory requirement and a scientific imperative for developing robust, scalable, and compliant bioprocesses. This workshop will deliver practical tools and advanced strategies for designing and executing process characterization studies that generate actionable insights.
Experts will cover how to define CPPs (critical process parameters) and CQAs (critical quality attributes), apply risk-based approaches, and integrate statistical modeling and digital tools into the characterization framework. Attendees will also gain insights into regulatory expectations, accelerated development timelines, and how leading organizations are future-proofing their process characterization programs to align with evolving global requirements.
Goals:
- Provide proven methodologies for designing and executing effective process characterization studies.
- Share case studies demonstrating speed–quality balance in accelerated development.
- Explore regulatory perspectives on global alignment and expectations.
- Highlight emerging digital and statistical approaches that enhance process understanding.
The BPI West Plenary Session sets the tone for the entire conference, bringing together some of the most visionary leaders, scientific pioneers, and bold innovators in bioprocessing and advanced therapies. Designed to inspire as much as it informs, this session looks beyond incremental improvements to explore how our industry can achieve transformative change.
Keynote speakers will share forward-looking perspectives on the breakthroughs, technologies, and collaborative models that are reshaping biopharmaceutical development and manufacturing. From next-generation biologics and cell and gene therapies to the role of digital transformation, AI, and sustainability, the plenary session will challenge attendees to think differently about how we innovate, accelerate, and deliver medicines to patients worldwide.
This session is not just about where the field is today - it’s about charting the course for what comes next.